World-Class Cardiac Arrhythmia Management
Confronting the burden of cardiac arrhythmias
The global burden of cardiac arrhythmias is staggering. Patients with atrial tachycardias (ATs) and atrial fibrillation (AF) face an increased risk for stroke, dementia, heart failure and death,1 and the number of patients with AF is expected to double in the next 40 years.2 Ventricular tachycardia (VT) and ventricular fibrillation (VF) are even more serious. Sustained VT is fatal. Analysts estimate that annually almost 4 million people experience sudden cardiac death worldwide, with about half of those deaths attributed to VT,3 including approximately 300,000 in the United States.4
We are recognized as an industry leader in arrhythmia management. Our electrophysiology (EP) and cardiac rhythm management (CRM) solutions can help you and your patients manage a range of cardiac arrhythmias, from the most common to the most dangerous.